Medi Assist Healthcare Services Ltd
MEDIASSIST NSE
Medi Assist Healthcare Services Ltd
InsuranceNSE: MEDIASSIST BSE: 544088 Insurance Distribution
Key Fundamentals
MicrocapInsurance DistributionInsuranceMarket Cap
₹2,723 Cr
Volatility
Moderate
P/E Ratio
28.39
EBITDA
₹160 Cr
Return on Equity
16.59%
Debt to Equity
0.06
Book Value
₹112.31
EPS
₹12.98
52W High
₹575.55
52W Low
₹293
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Medi Assist Healthcare Services Ltd insights
38 extracted metrics + investor summaries across FY19–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
3- Promoter holding is low: 4.61%
- Tax rate seems low
- Dividend payout has been low at 14.4% of profits over last 3 years
Growth Rate
Revenue Growth
21.10% ↗
Net Income Growth
-48.48% ↗
Cash Flow Change
108.03% ↗
ROE
12.02% ↗
ROCE
13.29% ↘
EBITDA Margin (Avg.)
-27.05% ↘
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 48d agoAI opinion · based on fundamentals
Risk medium
Medi Assist Healthcare Services is a health insurance TPA/insurtech platform with a market cap of ~₹2,780 crore, trading at a PE of 31.3x. The company delivered FY26 consolidated revenue of ₹905 crore (25% YoY growth) with a 5-year sales CAGR of 23%, though PAT dipped marginally to ₹89 crore in FY26 from ₹92 crore in FY25 and the stock has declined 29% over the past year.
Bull Case 8
- Strong revenue growth trajectory — FY26 consolidated sales of ₹905 crore, up 25% YoY from ₹723 crore in FY25, with a 5-year compounded sales CAGR of 23%
- Premium under management reached ₹15,829 crore as of Dec 2024, up 16.6% YoY, providing visibility on future revenue streams
- Retail premium segment growing at 31.2% YoY (₹2,050 crore), faster than overall group premium growth of 14.7%, indicating diversification
- Company is almost debt-free with reduced leverage, lowering financial risk and interest burden
- High group account retention rate of 94.3%, demonstrating client stickiness and recurring revenue characteristics
- 5-year compounded profit CAGR of 32%, reflecting operating leverage as the business scales
- Operating EBITDA margin maintained above 19-21% range (FY26 OPM at 18.9%, FY25 at 20.6%), indicating platform scalability
- Dividend yield of 1.07% with a 17% payout in FY26, signalling improving shareholder returns from a near-zero payout in FY25
Bear Case 8
- Stock has declined 29% over the past year, significantly underperforming the broader market and eroding investor wealth
- Promoter holding is extremely low at just 4.61%, raising governance and alignment concerns for minority shareholders
- FY26 PAT declined to ₹89 crore from ₹92 crore in FY25 despite 25% revenue growth, with OPM compressing from 20.6% to 18.9%
- TTM profit growth of only 9% versus 25% revenue growth indicates margin pressure and rising costs (depreciation up from ₹56 crore to ₹77 crore in FY26)
- PE of 31.3x is elevated for a company with single-digit near-term profit growth, implying high expectations are priced in
- ROE has trended down from 17% (5-year average) to 14% in the last year, suggesting declining capital efficiency
- Interest costs more than doubled from ₹10.3 crore in FY25 to ₹21.4 crore in FY26, potentially linked to acquisitions or working capital needs
- Low 3-year average dividend payout of 14.4% of profits, with inconsistent payout history (0% in FY25, 42% in FY24), limiting income-oriented appeal
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 48d ago Positives 1
- Raising stake in UK unit Jun 24
Medi Assist to acquire 31.75% additional shares in Mayfair We Care Limited for GBP 589,270, increasing holding from 60% to 91.75%, strengthening control over its UK subsidiary.
TL;DR: Medi Assist is consolidating ownership of its UK subsidiary Mayfair We Care, signaling confidence in international operations. No negative developments reported in this period. The move toward near-full ownership of the UK unit could unlock operational synergies, though the investment size is modest. Trend appears stable with a slight international expansion tilt.
Quarterly Results
| Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 136 | 141 | 166 | 167 | 168 | 181 | 186 | 189 | 191 | 233 | 240 | 242 | 237 |
| Expenses | 105 | 118 | 132 | 130 | 132 | 142 | 146 | 148 | 149 | 193 | 195 | 194 | 189 |
| Operating Profit | 31 | 22 | 34 | 37 | 35 | 38 | 40 | 41 | 42 | 40 | 45 | 48 | 48 |
| OPM % | 23% | 16% | 20% | 22% | 21% | 21% | 21% | 22% | 22% | 17% | 19% | 20% | 20% |
| Other Income | 2 | 5 | 4 | 4 | 5 | 6 | 4 | 8 | 7 | 2 | -7 | 3 | 10 |
| Interest | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 4 | 5 | 8 | 8 | 2 | 2 |
| Depreciation | 8 | 8 | 11 | 12 | 14 | 14 | 14 | 14 | 14 | 21 | 21 | 21 | 22 |
| PBT | 23 | 18 | 26 | 28 | 25 | 30 | 27 | 30 | 31 | 13 | 8 | 28 | 35 |
| Tax % | 32% | 3% | 17% | 9% | 24% | 29% | -10% | 28% | 26% | 40% | 51% | -95% | 21% |
| Net Profit | 16 | 18 | 21 | 26 | 19 | 21 | 30 | 22 | 23 | 8 | 4 | 54 | 28 |
| EPS in Rs | 2.3 | 2.58 | 2.98 | 3.58 | 2.68 | 2.99 | 4.19 | 3.05 | 3.18 | 1.13 | 0.56 | 7.16 | 3.71 |
Profit & Loss
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 277 | 319 | 323 | 394 | 505 | 635 | 723 | 905 | 951 |
| Expenses | 194 | 237 | 247 | 302 | 385 | 501 | 569 | 730 | 770 |
| Operating Profit | 82 | 82 | 76 | 92 | 120 | 133 | 154 | 175 | 181 |
| OPM % | 30% | 26% | 23% | 23% | 24% | 21% | 21% | 19% | 19% |
| Other Income | -14 | 7 | 11 | 21 | 12 | -5 | 24 | 5 | 9 |
| Interest | 4 | 4 | 6 | 3 | 3 | 3 | 10 | 23 | 20 |
| Depreciation | 23 | 27 | 32 | 28 | 27 | 43 | 56 | 77 | 85 |
| PBT | 41 | 59 | 49 | 81 | 102 | 82 | 112 | 80 | 85 |
| Tax % | 37% | 41% | 47% | 21% | 28% | 16% | 18% | -11% | — |
| Net Profit | 26 | 35 | 26 | 64 | 74 | 69 | 92 | 89 | 94 |
| EPS in Rs | 7,255 | 9,576 | 7,065 | 9.33 | 10.76 | 9.53 | 12.89 | 11.78 | 12.56 |
| Div. Payout % | 0% | 0% | 0% | 20% | 18% | 26% | 0% | 17% | — |
Balance Sheet
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.04 | 0.04 | 0.04 | 34 | 34 | 35 | 35 | 37 |
| Reserves | 218 | 212 | 290 | 303 | 342 | 437 | 506 | 802 |
| Borrowings | 98 | 115 | 35 | 27 | 31 | 26 | 204 | 54 |
| Other Liabilities | 202 | 231 | 220 | 238 | 295 | 344 | 412 | 479 |
| Total Liabilities | 518 | 558 | 545 | 602 | 702 | 842 | 1,158 | 1,372 |
| Fixed Assets | 142 | 138 | 119 | 99 | 171 | 246 | 306 | 659 |
| CWIP | 3 | 1 | 1 | 6 | 0 | 3 | 4 | 0 |
| Investments | 88 | 72 | 111 | 201 | 44 | 77 | 274 | 158 |
| Other Assets | 285 | 347 | 315 | 296 | 487 | 516 | 574 | 556 |
| Total Assets | 518 | 558 | 545 | 602 | 702 | 842 | 1,158 | 1,372 |
Cash Flow
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating | 35 | 19 | 139 | 64 | 81 | 66 | 138 | 118 |
| Investing | -21 | -22 | -61 | -83 | -10 | -55 | -218 | -160 |
| Financing | -10 | -12 | -10 | -30 | -32 | -15 | 112 | 12 |
| Net Cash Flow | 4 | -15 | 69 | -49 | 39 | -3 | 32 | -30 |
| Free Cash Flow | 14 | -2 | 126 | 62 | 53 | 49 | 92 | 62 |
| CFO/OP | 97 | 70 | 141 | 116 | 100 | 70 | 89 | 68 |
Ratios
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 119 | 78 | 137 | 110 | 92 | 103 | 112 | 116 |
| Cash Conversion Cycle | 119 | 78 | 137 | 110 | 92 | 103 | 112 | 116 |
| Working Capital Days | -80 | -103 | -73 | -59 | -66 | -43 | -105 | 25 |
| ROCE % | — | 20% | 19% | 23% | 26% | 23% | 19% | 14% |
Documents
2
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Medi Assist reports FY26 revenue up 25.1%, becomes debt-free, with ₹904.8 Cr revenue and ₹174.6 Cr EBITDA. 1d - Medi Assist reports FY26 revenue up 25.1%, becomes debt-free, with ₹904.8 Cr revenue and ₹174.6 Cr EBITDA.
4
Announcement under Regulation 30 (LODR)-Change in Management
9h - Medi Assist appoints three additional senior managerial personnel effective May 9, 2026. 9h - Medi Assist appoints three additional senior managerial personnel effective May 9, 2026.
5
Announcement under Regulation 30 (LODR)-Change in Management
9h - Medi Assist appoints PwC Services LLP as internal auditor for FY2026-27, effective May 9, 2026. 9h - Medi Assist appoints PwC Services LLP as internal auditor for FY2026-27, effective May 9, 2026.
Frequently Asked Questions about Medi Assist Healthcare Services Ltd
What does Medi Assist Healthcare Services Ltd do?
Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.[1]
Where is Medi Assist Healthcare Services Ltd (MEDIASSIST) listed?
Medi Assist Healthcare Services Ltd is listed on the Indian stock exchanges. It is listed on NSE: MEDIASSIST and BSE: 544088. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Medi Assist Healthcare Services Ltd belong to?
Medi Assist Healthcare Services Ltd operates in the Insurance sector within the Insurance Distribution industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Medi Assist Healthcare Services Ltd?
Medi Assist Healthcare Services Ltd has a market capitalisation of approximately ₹2723.26 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Medi Assist Healthcare Services Ltd?
The Price-to-Earnings (PE) ratio of Medi Assist Healthcare Services Ltd is 28.39. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Medi Assist Healthcare Services Ltd?
Over the past 52 weeks, Medi Assist Healthcare Services Ltd has traded between a low of ₹293 and a high of ₹575.55. This range helps investors understand the stock's price volatility and recent trading levels.
Does Medi Assist Healthcare Services Ltd pay dividends?
Yes, Medi Assist Healthcare Services Ltd has a dividend yield of 0.55%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Medi Assist Healthcare Services Ltd?
Medi Assist Healthcare Services Ltd has a Return on Equity (ROE) of 16.59%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Medi Assist Healthcare Services Ltd on Tapetide?
On Tapetide, you can view Medi Assist Healthcare Services Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.[1]